The Senate Finance Committee convened a hearing entitled “Lower Health Care Costs for Americans: Understanding the Benefits of the Inflation Reduction Act (IRA).” The Senators and witnesses spoke to the successes and potential draw backs of the programs enacted through the IRA, including the Part D redesign, capping insulin costs, the Medicare Drug Price Negotiation Program, inflation rebates, and the… (Slifer, September 17, 2024) #Cost-Sharing, #Drug Pricing, #Insurance Coverage, #Medicare Part D, #Prescription Drugs